His Internal medicine study frequently draws parallels with other fields, such as Receptor. His study in Estrogen extends to Endocrinology with its themes. Estrogen is closely attributed to Endocrinology in his work. His research on Pathology often connects related topics like Cerebrospinal fluid. Disease and Tau protein are commonly linked in his work. His research on Tau protein often connects related areas such as Disease. He combines Gastroenterology and Internal medicine in his research. With his scientific publications, his incorporates both Alzheimer's disease and Atrophy. Marinus A. Blankenstein incorporates Atrophy and Alzheimer's disease in his research.
Marinus A. Blankenstein applies his multidisciplinary studies on Internal medicine and Gastroenterology in his research. He combines Gastroenterology and Internal medicine in his studies. Marinus A. Blankenstein merges many fields, such as Endocrinology and Hormone, in his writings. In his articles, he combines various disciplines, including Hormone and Cancer. While working in this field, Marinus A. Blankenstein studies both Cancer and Estrogen receptor. Marinus A. Blankenstein integrates several fields in his works, including Estrogen receptor and Breast cancer. Marinus A. Blankenstein combines Breast cancer and Estrogen in his research. His study ties his expertise on Endocrinology together with the subject of Estrogen. His Meningioma research extends to Pathology, which is thematically connected.
While the research belongs to areas of Feces, Marinus A. Blankenstein spends his time largely on the problem of Paleontology, intersecting his research to questions surrounding Test (biology). Marinus A. Blankenstein frequently studies issues relating to Paleontology and Test (biology). As a part of the same scientific study, he usually deals with the Multiple sclerosis, concentrating on Psychiatry and frequently concerns with Psychological intervention. His research combines Psychiatry and Psychological intervention. As part of his studies on Internal medicine, Marinus A. Blankenstein frequently links adjacent subjects like Receiver operating characteristic. His study ties his expertise on Internal medicine together with the subject of Confounding. Marinus A. Blankenstein combines Gastroenterology and Oncology in his studies. His work blends Oncology and Gastroenterology studies together. His Cognitive psychology study frequently draws connections to adjacent fields such as Checklist.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.
Niklas Mattsson;Henrik Zetterberg;Oskar Hansson;Niels Andreasen.
Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients.
Maxime P. Look;Wim L. J. van Putten;Michael J. Duffy;Nadia Harbeck.
Journal of the National Cancer Institute (2002)
Accuracy of 6 Routine 25-Hydroxyvitamin D Assays: Influence of Vitamin D Binding Protein Concentration
Annemieke C. Heijboer;Marinus A. Blankenstein;Ido P. Kema;Madelon M. Buijs.
Clinical Chemistry (2012)
Amyloid-β(1–42), Total Tau, and Phosphorylated Tau as Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease
Cees Mulder;Nicolaas A. Verwey;Wiesje M. van der Flier;Femke H. Bouwman.
Clinical Chemistry (2010)
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers
Niklas Mattsson;Ulf Andreasson;Staffan Persson;Hiroyuki Arai.
Alzheimers & Dementia (2011)
CSF biomarker variability in the Alzheimer's Association quality control program
Niklas Mattsson;Niklas Mattsson;Ulf Andreasson;Staffan Persson;Maria C. Carrillo.
Alzheimers & Dementia (2013)
Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease.
Daniela Galimberti;Niki Schoonenboom;Philip Scheltens;Chiara Fenoglio.
JAMA Neurology (2006)
The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance
B.J. Potter van Loon;C. Kluft;J.K. Radder;M.A. Blankenstein.
Metabolism-clinical and Experimental (1993)
Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort
N. S. M. Schoonenboom;Fransje Reesink;N. A. Verwey;M. I. Kester.
Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: Synergistic action of insulin and estrogen
Bart van der Burg;Gerard R. Rutteman;Marinus A. Blankenstein;Siegfried W. de Laat.
Journal of Cellular Physiology (1988)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: